Evidence map›Paper›PMID 28280216›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2017

Eric W Price, Kathryn E Carnazza, Sean D Carlin, Andrew Cho, Kimberly J Edwards, Kuntal K Sevak, Jonathan M Glaser, Elisa de Stanchina, Yelena Y Janjigian, Jason S Lewis

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. In Vivo Detection ofInternational journal of biomedical imaging · 2024
    Article
  4. Review
  5. Article
  6. Identification of prognostic genes in oral squamous cell carcinoma microenvironment.Cancer biomarkers : section A of Disease markers · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  12. Review
  13. Antibody-Targeted Imaging of Gastric Cancer.Molecules (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Eric W PriceDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kathryn E CarnazzaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sean D CarlinDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Andrew ChoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kimberly J EdwardsDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Kuntal K SevakDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jonathan M GlaserDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Elisa de StanchinaAntitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Yelena Y JanjigianGastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Jason S LewisDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York lewisj2@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hepatocyte growth factor (HGF) binding antibody rilotumumab (AMG102) was modified for use as a

Indexed as

Patient SelectionPositron-Emission TomographyRadioisotopesZirconiumAnimalsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedCell Line, TumorCell Transformation, NeoplasticDeferoxamineFemaleGene Expression Regulation, NeoplasticHepatocyte Growth FactorHumansImmunoconjugatesMiceAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedDeferoxamineHepatocyte Growth FactorHGF protein, humanImmunoconjugatesRadioisotopesrilotumumabZirconiumAMG102hepatocyte growth factorHGFMETpatient-derived xenograftPETrilotumumabscatter factor

Identifiers

PMID28280216
PMCPMC5577625
OpenAlexW2591849521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.